Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 03
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-0.57%
|
$35,346
$43.01 P/Share
|
Nov 03
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,868
+1.27%
|
-
|
Aug 23
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
3
+1.02%
|
-
|
Aug 23
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.29%
|
-
|
Aug 23
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.26%
|
-
|
Aug 23
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+1.27%
|
-
|
Aug 23
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.3%
|
-
|
Aug 23
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.24%
|
-
|
Aug 23
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
23
+1.27%
|
-
|
Aug 23
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
18
+1.3%
|
-
|
Jul 28
2022
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27
+0.02%
|
-
|
Jul 28
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-0.58%
|
$35,776
$43.93 P/Share
|
Jul 28
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,891
+1.29%
|
-
|
Jul 01
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+50.0%
|
-
|
Jul 01
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
289
+50.0%
|
-
|
Jul 01
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1,885
+50.0%
|
-
|
Jul 01
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,257
+50.0%
|
-
|
Jul 01
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
1,760
+50.0%
|
-
|
Jun 21
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
12
+16.67%
|
-
|
Jun 21
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
43
+3.0%
|
-
|
Jun 08
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
3
+1.23%
|
-
|
Jun 08
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
Jun 08
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
Jun 08
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
Jun 08
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.24%
|
-
|
Jun 08
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
20
+1.27%
|
-
|
May 31
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$329,000
$47.08 P/Share
|
May 25
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
7,116
-50.41%
|
$313,104
$44.61 P/Share
|
Apr 28
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
4,799
-3.26%
|
$211,156
$44.88 P/Share
|
Apr 28
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
10,460
+6.64%
|
-
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
6
+1.24%
|
-
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
Mar 28
2022
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
Mar 28
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
Mar 28
2022
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
Mar 28
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+1.04%
|
-
|
Mar 28
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.19%
|
-
|
Mar 28
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
19
+1.22%
|
-
|
Feb 25
2022
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
7,483
-98.28%
|
$359,184
$48.63 P/Share
|
Feb 23
2022
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-51.08%
|
$56,682
$47.12 P/Share
|
Feb 23
2022
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,361
+50.0%
|
-
|
Feb 23
2022
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
15,872
-10.4%
|
$745,984
$47.12 P/Share
|
Feb 23
2022
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
35,863
+19.03%
|
-
|
Feb 23
2022
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,749
-48.71%
|
$552,203
$47.12 P/Share
|
Feb 23
2022
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,119
+50.0%
|
-
|
Feb 22
2022
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
11,757
-45.44%
|
$552,579
$47.12 P/Share
|
Feb 22
2022
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
3,530
-12.01%
|
$165,910
$47.12 P/Share
|
Feb 22
2022
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
29,403
+50.0%
|
-
|